Zhen Xue , Shengguan Song , Changan Hu , Shanglong Zhao , Juan Wang
{"title":"患有阻塞性睡眠呼吸暂停综合征的老年男性患者患肌少症和骨质疏松症的风险:一项多中心研究","authors":"Zhen Xue , Shengguan Song , Changan Hu , Shanglong Zhao , Juan Wang","doi":"10.1016/j.jocd.2024.101481","DOIUrl":null,"url":null,"abstract":"<div><p>The aim of this study was to assess the risk of sarcopenia and osteoporosis in elderly patients with obstructive sleep apnea syndrome (OSAS). We recruited both OSAS patients and non-OSAS subjects from multiple centers and evaluated their skeletal muscle index (SMI), bone mineral density (BMD), and inflammatory factors. All participants underwent polysomnography (PSG) testing, handgrip strength testing, chest CT, and dual-energy x-ray BMD testing. Based on the PSG diagnosis results, the participants were divided into a control group and an OSAS group. The analysis results revealed a higher incidence of sarcopenia in the OSAS group (<em>χ<sup>2</sup></em> = 22.367; <em>P</em> = 0.000) and osteoporosis (<em>χ<sup>2</sup></em> = 11.730<sup>a</sup>; <em>P</em> = 0.001). There were statistically significant differences in BMI (<em>P</em> = 0.000), grip strength (<em>P</em> = 0.000), SMI (<em>P</em> = 0.000), bone density (<em>P</em> = 0.000) and vitamin D (<em>P</em> = 0.000). The independent sample t test results showed that there was no statistical difference between IL-6 (<em>P</em> = 0.247) and CRP (<em>P</em> = 0.246). Considering the potential impact of body weight on the observed indicators, we employed covariance analysis to calculate the modified <em>P</em> value for each observation indicator. The findings demonstrated that the grip strength, IL-6, and CRP levels in the OSAS group were significantly higher compared to the control group. Conversely, the SMI, bone density, and Vitamin D levels were found to be significantly lower in the OSAS group than in the control group. These results suggest a higher likelihood of sarcopenia and osteoporosis among OSAS patients. Further studies should be conducted in larger study populations.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"27 2","pages":"Article 101481"},"PeriodicalIF":1.7000,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of Sarcopenia and Osteoporosis in Elderly Male Patients with Obstructive Sleep Apnea Syndrome: A Multicenter Study\",\"authors\":\"Zhen Xue , Shengguan Song , Changan Hu , Shanglong Zhao , Juan Wang\",\"doi\":\"10.1016/j.jocd.2024.101481\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The aim of this study was to assess the risk of sarcopenia and osteoporosis in elderly patients with obstructive sleep apnea syndrome (OSAS). We recruited both OSAS patients and non-OSAS subjects from multiple centers and evaluated their skeletal muscle index (SMI), bone mineral density (BMD), and inflammatory factors. All participants underwent polysomnography (PSG) testing, handgrip strength testing, chest CT, and dual-energy x-ray BMD testing. Based on the PSG diagnosis results, the participants were divided into a control group and an OSAS group. The analysis results revealed a higher incidence of sarcopenia in the OSAS group (<em>χ<sup>2</sup></em> = 22.367; <em>P</em> = 0.000) and osteoporosis (<em>χ<sup>2</sup></em> = 11.730<sup>a</sup>; <em>P</em> = 0.001). There were statistically significant differences in BMI (<em>P</em> = 0.000), grip strength (<em>P</em> = 0.000), SMI (<em>P</em> = 0.000), bone density (<em>P</em> = 0.000) and vitamin D (<em>P</em> = 0.000). The independent sample t test results showed that there was no statistical difference between IL-6 (<em>P</em> = 0.247) and CRP (<em>P</em> = 0.246). Considering the potential impact of body weight on the observed indicators, we employed covariance analysis to calculate the modified <em>P</em> value for each observation indicator. The findings demonstrated that the grip strength, IL-6, and CRP levels in the OSAS group were significantly higher compared to the control group. Conversely, the SMI, bone density, and Vitamin D levels were found to be significantly lower in the OSAS group than in the control group. These results suggest a higher likelihood of sarcopenia and osteoporosis among OSAS patients. Further studies should be conducted in larger study populations.</p></div>\",\"PeriodicalId\":50240,\"journal\":{\"name\":\"Journal of Clinical Densitometry\",\"volume\":\"27 2\",\"pages\":\"Article 101481\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Densitometry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1094695024000167\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Densitometry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094695024000167","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
本研究旨在评估患有阻塞性睡眠呼吸暂停综合症(OSAS)的老年患者患肌肉疏松症和骨质疏松症的风险。我们从多个中心招募了阻塞性睡眠呼吸暂停综合症患者和非阻塞性睡眠呼吸暂停综合症受试者,并评估了他们的骨骼肌指数(SMI)、骨矿物质密度(BMD)和炎症因子。所有参与者都接受了多导睡眠图(PSG)测试、手握力测试、胸部 CT 和双能 X 射线 BMD 测试。根据 PSG 诊断结果,参与者被分为对照组和 OSAS 组。分析结果显示,OSAS 组的肌少症(= 22.367;= 0.000)和骨质疏松症(= 11.730;= 0.001)发生率较高。BMI(= 0.000)、握力(= 0.000)、SMI(= 0.000)、骨密度(= 0.000)和维生素 D(= 0.000)差异有统计学意义。独立样本 t 检验结果显示,IL-6 ( = 0.247) 和 CRP ( = 0.246) 之间没有统计学差异。考虑到体重对观察指标的潜在影响,我们采用协方差分析法计算了各观察指标的修正值。研究结果表明,OSAS组的握力、IL-6和CRP水平明显高于对照组。相反,OSAS 组的 SMI、骨密度和维生素 D 水平则明显低于对照组。这些结果表明,OSAS 患者更有可能患上肌肉疏松症和骨质疏松症。应在更大的研究人群中开展进一步研究。
Risk of Sarcopenia and Osteoporosis in Elderly Male Patients with Obstructive Sleep Apnea Syndrome: A Multicenter Study
The aim of this study was to assess the risk of sarcopenia and osteoporosis in elderly patients with obstructive sleep apnea syndrome (OSAS). We recruited both OSAS patients and non-OSAS subjects from multiple centers and evaluated their skeletal muscle index (SMI), bone mineral density (BMD), and inflammatory factors. All participants underwent polysomnography (PSG) testing, handgrip strength testing, chest CT, and dual-energy x-ray BMD testing. Based on the PSG diagnosis results, the participants were divided into a control group and an OSAS group. The analysis results revealed a higher incidence of sarcopenia in the OSAS group (χ2 = 22.367; P = 0.000) and osteoporosis (χ2 = 11.730a; P = 0.001). There were statistically significant differences in BMI (P = 0.000), grip strength (P = 0.000), SMI (P = 0.000), bone density (P = 0.000) and vitamin D (P = 0.000). The independent sample t test results showed that there was no statistical difference between IL-6 (P = 0.247) and CRP (P = 0.246). Considering the potential impact of body weight on the observed indicators, we employed covariance analysis to calculate the modified P value for each observation indicator. The findings demonstrated that the grip strength, IL-6, and CRP levels in the OSAS group were significantly higher compared to the control group. Conversely, the SMI, bone density, and Vitamin D levels were found to be significantly lower in the OSAS group than in the control group. These results suggest a higher likelihood of sarcopenia and osteoporosis among OSAS patients. Further studies should be conducted in larger study populations.
期刊介绍:
The Journal is committed to serving ISCD''s mission - the education of heterogenous physician specialties and technologists who are involved in the clinical assessment of skeletal health. The focus of JCD is bone mass measurement, including epidemiology of bone mass, how drugs and diseases alter bone mass, new techniques and quality assurance in bone mass imaging technologies, and bone mass health/economics.
Combining high quality research and review articles with sound, practice-oriented advice, JCD meets the diverse diagnostic and management needs of radiologists, endocrinologists, nephrologists, rheumatologists, gynecologists, family physicians, internists, and technologists whose patients require diagnostic clinical densitometry for therapeutic management.